Presentation NY Valves 2025 Management of HALT After TAVR: Anticoagulation, Which Agent, How Long Presenter: George D. Dangas June 26, 2025
Presentation NY Valves 2025 Long-Term Outcomes After TAVR With a Self-Expanding Prosthesis Presenter: Won-Keun Kim June 26, 2025
Presentation NY Valves 2025 Transcarotid Access for TAVR Using a Balloon Expandable Valve: Contemporary Results from a Real-World Registry Presenter: Keith B. Allen June 26, 2025
Presentation NY Valves 2025 Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice Presenter: Alexandra J. Lansky June 26, 2025
Presentation NY Valves 2025 What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis? Presenter: Sreekanth Vemulapalli June 26, 2025
Presentation NY Valves 2025 Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management Presenter: Tamim M. Nazif June 26, 2025
Presentation NY Valves 2025 Echo Assessment Remains the Gold Standard Presenter: Leo Marcoff June 26, 2025
Presentation NY Valves 2025 Not if the Invasive Gradients Look Fine Presenter: Brian K. Whisenant June 26, 2025
Presentation NY Valves 2025 Paravalular Leak After TAVR: When to Treat and Options for Closure Presenter: Mackram F. Eleid June 26, 2025
Presentation NY Valves 2025 A Femoral Complication Where Alternative Access Should Have Been Considered Presenter: Rajiv Tayal June 26, 2025
Presentation NY Valves 2025 When the PCI Performed Prior to TAVR Goes South, Maybe I Should Have Waited Until After the TAVR . . . Presenter: Mahesh V. Madhavan June 26, 2025
Presentation NY Valves 2025 Bioprosthetic Valve Remodelling: Optimizing Hemodynamics During TAVR in SAVR Presenter: Fabio Sandoli de Brito June 26, 2025
Presentation NY Valves 2025 Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR Presenter: Robert Gooley June 25, 2025
Presentation NY Valves 2025 Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis Presenter: Samir R. Kapadia June 25, 2025
Presentation NY Valves 2025 Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results Presenter: Hemal Gada June 25, 2025
Presentation NY Valves 2025 National Trends in Aortic Valve Replacement in Patients 65 Years and Younger Presenter: Vikrant Jagadeesan June 25, 2025
Presentation NY Valves 2025 Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors Presenter: Hugo Poinsignon June 25, 2025
Presentation NY Valves 2025 Age Considerations for Aortic Progression with BAV: When Is TAVR Still Acceptable? Presenter: Melissa Levack June 25, 2025
Presentation NY Valves 2025 Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR Presenter: Muhammad Suleman June 25, 2025
Presentation NY Valves 2025 Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials Presenter: Yasser M. Sammour June 25, 2025